Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. [Phase 3]

View source ↗

Summary

Phase 3 study comparing the anti-atherosclerotic effect of torcetrapib added to atorvastatin versus atorvastatin alone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torcetrapib (torcetrapib)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hypercholesterolemia, Familial, Hyperlipidemia | Phase 3 | Status: COMPLETED